Xenograft model systems for human melanoma.

[1]  J. Rygaard,et al.  Heterotransplantation of a human malignant tumour to "Nude" mice. , 2009, Acta pathologica et microbiologica Scandinavica.

[2]  I. Fidler,et al.  Critical factors in the biology of human cancer metastasis. , 1995, The American surgeon.

[3]  D. Buchsbaum.  Experimental approaches to increase radiolabeled antibody localization in tumors. , 1995, Cancer research.

[4]  S. Knox,et al.  Overview of studies on experimental radioimmunotherapy. , 1995, Cancer research.

[5]  E. Rofstad.  Metastatic behavior of human tumors in congenitally athymic nude mice: Intrinsic properties of the tumor cells and host immune reactivity , 1995, International journal of cancer.

[6]  E. Rofstad,et al.  Growth rates or radiobiological hypoxia are not correlated with local metabolite content in human melanoma xenografts with similar vascular network. , 1995, British Journal of Cancer.

[7]  H. Lyng,et al.  Detection of necrosis in human tumour xenografts by proton magnetic resonance imaging. , 1995, British Journal of Cancer.

[8]  E. Rofstad,et al.  Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern. , 1994, British Journal of Cancer.

[9]  H. Lyng,et al.  31P-nuclear magnetic resonance spectroscopy in vivo of six human melanoma xenograft lines: tumour bioenergetic status and blood supply. , 1993, British Journal of Cancer.

[10]  W. Silvers,et al.  Transgenic mouse model of malignant skin melanoma. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  E. Rofstad.  Comparative sensitivity of cells from human tumors and derivative tumor xenografts to radiation and heat treatments. , 1992, Journal of the National Cancer Institute.

[12]  T. Grogan,et al.  Growth and dissemination of human malignant melanoma cells in mice with severe combined immune deficiency. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[13]  H. Lyng,et al.  Blood flow in six human melanoma xenograft lines with different growth characteristics. , 1992, Cancer research.

[14]  R. Hoffman,et al.  Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[15]  E. Boven.  The Nude Mouse in Oncology Research , 1991 .

[16]  G. Murphy,et al.  Growth and metastasis of fresh human melanoma tissue in mice with severe combined immunodeficiency. , 1991, Cancer research.

[17]  M. Boyd,et al.  Practical spontaneous metastasis model for in vivo therapeutic studies using a human melanoma. , 1991, Cancer research.

[18]  I. Fidler,et al.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. , 1990, Cancer research.

[19]  J. Tímár,et al.  Selection and characterization of human melanoma lines with different liver‐colonizing capacity , 1990, International journal of cancer.

[20]  J. A. Lee.  Etiology, epidemiology, and prognosis of melanoma and skin neoplasms. , 1990, Current opinion in oncology.

[21]  A. Zietman,et al.  Residual immunity of athymic NCr/sed nude mice and the xenotransplantation of human tumors , 1990, International journal of cancer.

[22]  R K Jain,et al.  Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. , 1990, Cancer research.

[23]  R. Kerbel,et al.  Enhanced tumorigenicity, melanogenesis, and metastases of a human malignant melanoma after subdermal implantation in nude mice. , 1989, Journal of the National Cancer Institute.

[24]  I. Weissman,et al.  The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. , 1988, Science.

[25]  Donald E. Mosier,et al.  Transfer of a functional human immune system to mice with severe combined immunodeficiency , 1988, Nature.

[26]  R. Kerbel,et al.  Highly pigmented human melanoma variant which metastasizes widely in nude mice, including to skin and brain. , 1988, Cancer research.

[27]  C. Coleman,et al.  Hypoxia in tumors: a paradigm for the approach to biochemical and physiologic heterogeneity. , 1988, Journal of the National Cancer Institute.

[28]  R. Sutherland.  Cell and environment interactions in tumor microregions: the multicell spheroid model. , 1988, Science.

[29]  B. Giovanella,et al.  Correlation between response to chemotherapy of human tumors in patients and in nude mice , 1983, Cancer.

[30]  E. Rofstad,et al.  Vascular structure of five human malignant melanomas grown in athymic nude mice. , 1982, British Journal of Cancer.

[31]  D. Berd,et al.  Evaluation of a "nude" mouse-human tumor panel as a predictive secondary screen for cancer chemotherapeutic agents. , 1979, Journal of the National Cancer Institute.

[32]  M. Festing,et al.  An athymic nude mutation in the rat , 1978, Nature.

[33]  V. Courtenay,et al.  An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. , 1978, British Journal of Cancer.

[34]  S. Flanagan,et al.  'Nude', a new hairless gene with pleiotropic effects in the mouse. , 1966, Genetical research.

[35]  M. Bradl,et al.  Malignant melanoma in transgenic mice. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[36]  E. Rofstad,et al.  Comparative imaging of structure and metabolites in tumours. , 1991, International journal of radiation biology.

[37]  E. Rofstad.  Radiation biology of human tumour xenografts. , 1989, International journal of radiation biology.

[38]  D. Berd,et al.  Newer immunologic approaches to the treatment of patients with melanoma. , 1988, Seminars in oncology.